Securities Exchange Act of 1934
| DE | 0-32259 | 94-3267295 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
| 2820 Orchard Parkway, San Jose, CA | 95134 | |
| (Address of principal executive offices) | (Zip Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
This information shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: October 26, 2017 |
Align Technology, Inc. By: /s/ Roger E. George Roger E. George Vice President, Legal and Corporate Affairs and General Counsel |
| Exhibit No. | Description | |
| 99.1 | Press Release of Align Technology, Inc. dated October 26, 2017 |
SAN JOSE, CA -- (Marketwired - October 26, 2017) -
-- Q3 revenues up 38.3% year-over-year, up 8.1% sequentially to a record
$385.3 million
-- Q3 total Invisalign case shipments up 32.8% year-over-year to 236.1
thousand
-- Q3 Invisalign case shipments to teenage patients up 46.3% year-over-
year, up 26.5% sequentially
-- Q3 scanner and services revenues up 25.0% year-over-year, up 23.2%
sequentially to $43.7 million
-- Q3 diluted EPS $1.01, up 60.3% year-over-year
Align Technology, Inc. (NASDAQ: ALGN) today reported financial results for the third quarter ended September 30, 2017. Invisalign case shipments in the third quarter of 2017 (Q3'17) were 236.1 thousand, a 32.8% increase year-over-year. North America and International case shipments were up year-over-year 25.0% and 47.4%, respectively. Q3'17 Invisalign case shipments to teenage patients were 69.8 thousand, a 46.3% increase year-over-year. For Q3'17, revenues were $385.3 million, a 38.3% increase year-over-year, and net profit was $82.6 million, or $1.01 per diluted share, up 60.3% per diluted share compared to the same period in the prior year. Commenting on Align's Q3 2017 results, Align Technology President and CEO Joe Hogan said, "I'm pleased to report another strong quarter and results that exceeded our expectations across our key financial metrics including revenue, volume, margins, and EPS. Third quarter revenues increased 38.3% year-over-year driven by increased Invisalign volumes across all our geographies, as well as strong growth from iTero scanners. Our strong third quarter results also reflect accelerated growth from teenager patients in both North America and the Asia Pacific region, with total Invisalign shipments up 46.3% year-over-year and up 26.5% from the second quarter. On a sequential basis, revenues increased 8.1% driven by continued strength across Asia Pacific, which offset expected seasonality in Europe, as well as higher than expected revenues from shipments to SmileDirectClub." GAAP Summary Financial Comparisons Third Quarter Fiscal 2017
----------------------------------------------------------------------------
Q3'17 Q2'17 Q3'16 Q/Q Change Y/Y Change
----------------------------------------------------------------------------
Invisalign Case
Shipments* 236,065 231,890 177,755 +1.8% +32.8%
Net Revenues $385.3M $356.5M $278.6M +8.1% +38.3%
Clear Aligner** $341.6M $321.0M $243.7M +6.4% +40.2%
Scanner & Services $43.7M $35.4M $34.9M +23.2% +25.0%
Net Profit $82.6M $69.2M $51.4M +19.3% +60.7%
Diluted EPS $1.01 $0.85 $0.63 +$0.16 +$0.38
----------------------------------------------------------------------------
Note: Changes and percentages are based on actual values and may affect totals due to rounding * Invisalign Shipment figures do not include SmileDirectClub aligners ** Clear aligner revenue includes revenues from Invisalign clear aligners and SmileDirectClub aligners As of September 30, 2017, Align had $737.9 million in cash, cash equivalents and marketable securities compared to $676.6 million as of June 30, 2017. During Q3'17, Align concluded its previously announced $50.0 million accelerated stock repurchase program (ASR) receiving a total of 0.4 million shares at a weighted average share price of $146.48 under the ASR. We have $250.0 million remaining available for repurchases under the existing stock repurchase authorization. Q3 2017 Business Highlights
-- Align Technology Introduces a New Brand Identity for iTero® Scanning
System and Tools: Align announced a new global brand identity for the
company's leading iTero® scanning system and innovative tools at the
recent bi-annual Invisalign GP Summit customer event. The introduction
of a new, vibrant brand identity for the iTero scanner reflects its
critical and central role in digital treatment and the practice of the
future.
-- Patterson Dental and Align Technology Announce Distribution Agreement
for iTero® Element Intraoral Scanning System: Align announced a
distribution agreement for Align's iTero Element intraoral scanning
system. This agreement provides access to Patterson's sales force and
general dentist customers who are looking to grow their business through
practice digitization. The iTero scanner enables dentists to scan in as
little as 60 seconds, visualize changes in dentition, and perform
restorative and orthodontic workflows that enhance their patient care
and help them grow their practice.
-- Align Technology Moves Corporate Headquarters to New Buildings in San
Jose, California: In August, Align relocated its corporate headquarters
to a new location at 2820 Orchard Parkway, San Jose, CA. The Company had
purchased the new buildings in January 2017 in anticipation of the lease
expiration for its prior location.
-- Align Technology Expands Its Presence in Raleigh, North Carolina with
Larger Office to Support Continued Headcount Growth: Align has opened a
larger office in Raleigh, North Carolina to accommodate headcount growth
and leverage the area's diverse and broad-based talent resources. Align
intends to hire more than 200 employees over the next several years in
Raleigh in various areas illustrating its commitment to driving
continued innovation and supporting its expanding customer base
globally.
-- Align Technology Opens First Office in Canada to Support Continued
Growth: In August, Align opened its' first office in Canada to support
continued growth across the region. Canada is Align's second largest
country market and has a large opportunity for expansion and accelerated
growth. Sian Roberts, who joined Align earlier this year as VP and
General Manager, will lead the strategy and execution for Canada.
Q4 2017 Business Outlook For the fourth quarter of 2017 (Q4'17), Align provides the following guidance:
-- Invisalign case shipments in the range of 245 thousand to 250 thousand,
up approximately 29% to 32% over the same period a year ago.
-- Net revenues in the range of $391 million to $398 million, up
approximately 33% to 36% over the same period a year ago.
-- Diluted EPS in the range of $0.92 to $0.95.
Align Web Cast and Conference Call Align will host a conference call today, October 26, 2017 at 4:30 p.m. ET, 1:30 p.m. PT, to review its third quarter 2017 results, discuss future operating trends and the business outlook. The conference call will also be web cast live via the Internet. To access the webcast, go to the "Events & Presentations" section under Company Information on Align's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8261. An archived audio web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with conference number 13671493 followed by #. For international callers, please dial 201-612-7415 and use the same conference number referenced above. The telephonic replay will be available through 5:30 p.m. ET on November 9, 2017. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information. For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com. Forward-Looking Statement This news release, including the tables below, contains forward-looking statements, including statements regarding certain business metrics for the fourth quarter of 2017, including, but not limited to, anticipated net revenues, gross margin, operating expenses, operating profit, diluted earnings per share, tax rate and case shipments. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, difficulties predicting customer and consumer purchasing behavior, Align's ability to protect its intellectual property rights, continued compliance with regulatory requirements, competition from existing and new competitors, the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, or that the expected benefits of new or existing business relationships will not be achieved as anticipated, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, growth related risks, including capacity constraints and pressure on our internal systems and personnel, the security of customer and/or patient data is compromised for any reason, continued customer demand for our existing and new products, changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of our products by consumers and dental professionals, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to develop and successfully introduce new products and product enhancements and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the year ended December 31, 2016, which was filed with the Securities and Exchange Commission (SEC) on February 28, 2017, and its latest Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, which was filed with the SEC on August 3, 2017. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
ALIGN TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Three Months Ended Nine Months Ended
--------------------------- ---------------------------
September 30, September 30, September 30, September 30,
2017 2016 2017 2016
------------- ------------- ------------- -------------
Net revenues $ 385,267 $ 278,589 $ 1,052,090 $ 786,671
Cost of net revenues 92,779 69,387 253,060 191,626
------------- ------------- ------------- -------------
Gross profit 292,488 209,202 799,030 595,045
------------- ------------- ------------- -------------
Operating expenses:
Selling, general
and adminstrative 169,524 126,708 483,636 360,385
Research and
development 24,201 20,415 71,389 54,111
------------- ------------- ------------- -------------
Total operating
expenses 193,725 147,123 555,025 414,496
Income from
operations 98,763 62,079 244,005 180,549
Interest and other
income (expense),
net 3,750 1,463 8,607 1,161
------------- ------------- ------------- -------------
Net income before
provision for
income taxes and
equity in losses of
investee 102,513 63,542 252,612 181,710
Provision for income
taxes 18,344 11,698 26,508 39,172
Equity in losses of
investee, net of
tax 1,614 477 4,950 477
------------- ------------- ------------- -------------
Net income $ 82,555 $ 51,367 $ 221,154 $ 142,061
============= ============= ============= =============
Net income per
share:
Basic $ 1.03 $ 0.64 $ 2.76 $ 1.78
============= ============= ============= =============
Diluted $ 1.01 $ 0.63 $ 2.71 $ 1.74
============= ============= ============= =============
Shares used in
computing net
income per share:
Basic 80,163 79,977 80,086 79,920
============= ============= ============= =============
Diluted 81,789 81,466 81,757 81,523
============= ============= ============= =============
ALIGN TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 30, December 31,
2017 2016
------------- -------------
ASSETS
Current assets:
Cash and cash equivalents $ 362,613 $ 389,275
Marketable securities, short-term 316,454 250,981
Accounts receivable, net 321,328 247,415
Inventories 36,941 27,131
Prepaid expenses and other current assets 63,667 38,176
------------- -------------
Total current assets 1,101,003 952,978
Marketable securities, long-term 58,842 59,783
Property, plant and equipment, net 295,901 175,167
Equity method investments 52,875 45,061
Goodwill and intangible assets, net 90,070 81,998
Deferred tax assets 73,532 67,844
Other assets 25,400 13,320
------------- -------------
Total assets $ 1,697,623 $ 1,396,151
============= =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 45,942 $ 28,596
Accrued liabilities 173,851 134,332
Deferred revenues 241,576 191,407
------------- -------------
Total current liabilities 461,369 354,335
Income tax payable 45,375 45,133
Other long-term liabilities 8,921 1,294
------------- -------------
Total liabilities 515,665 400,762
Total stockholders' equity 1,181,958 995,389
------------- -------------
Total liabilities and stockholders' equity $ 1,697,623 $ 1,396,151
============= =============
ALIGN TECHNOLOGY, INC.
INVISALIGN BUSINESS METRICS*
Q1 Q2 Q3 Q4
2016 2016 2016 2016
Invisalign Average Selling Price (ASP):
Worldwide ASP $ 1,255 $ 1,285 $ 1,285 $ 1,230
International ASP $ 1,315 $ 1,345 $ 1,365 $ 1,315
Invisalign Cases Shipped by Geography:
North America 110,500 114,855 115,900 122,555
International 53,195 62,140 61,855 67,500
-------- -------- -------- --------
Total Cases Shipped 163,695 176,995 177,755 190,055
======== ======== ======== ========
YoY % growth 25.2% 22.4% 20.5% 18.5%
QoQ % growth 2.1% 8.1% 0.4% 6.9%
Number of Invisalign Doctors Cases Were
Shipped To:
North America 22,355 22,575 22,570 23,265
International 11,280 12,485 12,720 13,635
-------- -------- -------- --------
Total Doctors Cases Shipped To 33,635 35,060 35,290 36,900
======== ======== ======== ========
Invisalign Doctor Utilization Rates*:
North America 4.9 5.1 5.1 5.3
North American Orthodontists 10.4 10.7 11.1 11.3
North American GP Dentists 3.0 3.1 3.0 3.2
International 4.7 5.0 4.9 5.0
Total Utilization Rates 4.9 5.1 5.0 5.2
* # of cases shipped/# of doctors to
whom cases were shipped
Number of Invisalign Doctors Trained:
North America 875 1,125 1,300 1,420
International 1,605 1,760 1,315 2,280
-------- -------- -------- --------
Total Doctors Trained Worldwide 2,480 2,885 2,615 3,700
======== ======== ======== ========
Total to Date Worldwide 106,270 109,155 111,770 115,470
======== ======== ======== ========
--------
Fiscal Q1 Q2 Q3
2016 2017 2017 2017
Invisalign Average Selling Price (ASP):
Worldwide ASP $ 1,265 $ 1,270 $ 1,285 $ 1,310
International ASP $ 1,335 $ 1,325 $ 1,335 $ 1,390
Invisalign Cases Shipped by Geography:
North America 463,810 132,885 146,510 144,870
International 244,690 75,175 85,380 91,195
-------- -------- -------- --------
Total Cases Shipped 708,500 208,060 231,890 236,065
======== ======== ======== ========
YoY % growth 21.5% 27.1% 31.0% 32.8%
QoQ % growth 9.5% 11.5% 1.8%
Number of Invisalign Doctors Cases Were
Shipped To:
North America 34,065 23,910 24,695 24,845
International 20,415 14,955 16,570 17,760
-------- -------- -------- --------
Total Doctors Cases Shipped To 54,480 38,865 41,265 42,605
======== ======== ======== ========
Invisalign Doctor Utilization Rates*:
North America 13.6 5.6 5.9 5.8
North American Orthodontists 36.6 12.6 13.6 13.8
North American GP Dentists 7.6 3.1 3.3 3.1
International 12.0 5.0 5.2 5.1
Total Utilization Rates 13.0 5.4 5.6 5.5
* # of cases shipped/# of doctors to
whom cases were shipped
Number of Invisalign Doctors Trained:
North America 4,720 980 1,620 1,460
International 6,960 2,280 3,255 2,820
-------- -------- -------- --------
Total Doctors Trained Worldwide 11,680 3,260 4,875 4,280
======== ======== ======== ========
Total to Date Worldwide 115,470 118,730 123,605 127,885
======== ======== ======== ========
Note: Historical public data may differ due to rounding. Additionally,
rounding may affect totals.
*Invisalign business metrics exclude SmileDirectClub aligners.
ALIGN TECHNOLOGY, INC.
STOCK-BASED COMPENSATION
(in thousands)
Q1 Q2 Q3 Q4
2016 2016 2016 2016
Stock-based Compensation (SBC)
SBC included in Gross Profit $ 961 $ 932 $ 995 $ 1,078
SBC included in Operating Expenses 11,563 12,767 12,716 13,136
-------- -------- -------- --------
Total SBC Expense $ 12,524 $ 13,699 $ 13,711 $ 14,214
======== ======== ======== ========
--------
Fiscal Q1 Q2 Q3
2016 2017 2017 2017
Stock-based Compensation (SBC)
SBC included in Gross Profit $ 3,966 $ 925 $ 768 $ 833
SBC included in Operating Expenses 50,182 13,887 13,477 14,134
-------- -------- -------- --------
Total SBC Expense $ 54,148 $ 14,812 $ 14,245 $ 14,967
======== ======== ======== ========
ALIGN TECHNOLOGY, INC.
BUSINESS OUTLOOK SUMMARY
(unaudited)
The outlook figures provided below and elsewhere in this press release are
approximate in nature since Align's business outlook is difficult to
predict. Align's future performance involves numerous risks and
uncertainties and the company's results could differ materially from the
outlook provided. Some of the factors that could affect Align's future
financial performance and business outlook are set forth under "Forward
Looking Information" above in this press release.
Financial Outlook
(in millions, except per share amounts and percentages)
Q4'17 Guidance
--------------
GAAP
--------------
Net Revenues $391 - $398
Gross Margin 75.0% - 75.5%
Operating Expenses $198 - $202
Operating Margin 24.3% - 24.8%
Net Income per Diluted Share $0.92 - $0.95 (1)
Business Metrics: Q4'17
--------------
Case Shipments 245K - 250K
Capital Expenditure $55M - $60M
Depreciation & Amortization $10.5M - $11M
Diluted Shares Outstanding 81.9M (2)
Stock Based Compensation Expense $15.3M
Effective Tax Rate 22% (1)
(1) Includes the benefit from the adoption of the new accounting standard
update for share-based compensation
(2) Excludes any stock repurchases during the quarter
Investor Relations Contact Yin Cantor Align Technology, Inc. (408) 470-1044 ycantor@aligntec.com Press Contact Shannon Mangum Henderson Ethos Communication, Inc. (678) 261-7803 align@ethoscommunication.com